MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1001/archgenpsychiatry.2011.1870

Медицинская библиотека · Archives of general psychiatry · 2012

Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects.

Bodén Robert, Lundgren Maria, Brandt Lena, Reutfors Johan, Kieler Helle

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

CONTEXT: Knowledge about the effects of exposure to the newer antipsychotics during pregnancy is limited.

OBJECTIVE

To investigate the effects of maternal use of antipsychotics during pregnancy on gestational diabetes and fetal growth.

DESIGN

Population-based cohort study comparing women exposed and not exposed to antipsychotics during pregnancy. Exposure was defined as prescriptions filled.

SETTING

Swedish national health registers.

PARTICIPANTS

All women giving birth in Sweden from July 1, 2005, through December 31, 2009, grouped by filled prescriptions for (1) olanzapine and/or clozapine, the most obesogenic and diabetogenic antipsychotics (n = 169), (2) other antipsychotics (n = 338), or (3) no antipsychotics (n = 357,696).

MAIN OUTCOME MEASURES: Odds ratios (ORs) with 95% CIs for gestational diabetes and being small for gestational age (SGA) and large for gestational age for birth weight, birth length, and head circumference.

RESULTS

Exposure to other antipsychotics was associated with an increased risk of gestational diabetes (adjusted OR, 1.77 [95% CI, 1.04-3.03]). The risk increase with olanzapine and/or clozapine was of similar magnitude but not statistical significance (adjusted OR, 1.94 [95% CI, 0.97-3.91]). Infants exposed to either group of antipsychotics had increased risks of being SGA on birth weight, whereas only exposure to other antipsychotics yielded increased risks of being SGA for birth length and head circumference. None of the risks for SGA measurements remained significant after adjusting for maternal factors. There were no increased risks of being large for gestational age for birth weight or birth length after exposure to olanzapine and/or clozapine, but the risk increased for head circumference (OR, 3.02 [95% CI, 1.60-5.71]).

CONCLUSIONS

Women who used antipsychotics during pregnancy had increased risks of gestational diabetes. The increased risks of giving birth to an SGA infant seemed to be an effect of confounders, such as smoking. Except for macrocephaly, olanzapine and/or clozapine exposure was not associated with anabolic fetal growth.

Для цитирования: Bodén Robert, Lundgren Maria, Brandt Lena, Reutfors Johan, Kieler Helle. Antipsychotics during pregnancy: relation to fetal and maternal metabolic effects.. Archives of general psychiatry. 2012. DOI: 10.1001/archgenpsychiatry.2011.1870.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.